Somatuline Depot Drug Interactions: 85 Major, 110 Moderate
Somatuline Depot (Lanreotide Acetate) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Somatuline Depot. Always confirm against the full prescribing information.
100 interactions
Acarbose
The therapeutic efficacy of Acarbose can be decreased when used in combination with Lanreotide.
Level 2 evidence
Acenocoumarol
The serum concentration of Acenocoumarol can be increased when it is combined with Lanreotide.
Level 1 evidence
Alfuzosin
The metabolism of Alfuzosin can be decreased when combined with Lanreotide.
Level 1 evidence
Alogliptin
The therapeutic efficacy of Alogliptin can be decreased when used in combination with Lanreotide.
Level 2 evidence
Alprazolam
The metabolism of Alprazolam can be decreased when combined with Lanreotide.
Level 1 evidence
Aripiprazole
The metabolism of Aripiprazole can be decreased when combined with Lanreotide.
Level 1 evidence
Aripiprazole lauroxil
The metabolism of Aripiprazole lauroxil can be decreased when combined with Lanreotide.
Level 1 evidence
Articaine
The risk or severity of methemoglobinemia can be increased when Lanreotide is combined with Articaine.
Level 1 evidence
Atorvastatin
The metabolism of Atorvastatin can be decreased when combined with Lanreotide.
Level 1 evidence
Benzocaine
The risk or severity of methemoglobinemia can be increased when Lanreotide is combined with Benzocaine.
Level 1 evidence
Benzyl alcohol
The risk or severity of methemoglobinemia can be increased when Lanreotide is combined with Benzyl alcohol.
Level 1 evidence
Bexagliflozin
The therapeutic efficacy of Bexagliflozin can be decreased when used in combination with Lanreotide.
Level 2 evidence
Enter your NPI to unlock 31 major interactions for Somatuline Depot
Somatuline Depot (Lanreotide Acetate) has 308 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Somatuline Depot (Lanreotide Acetate) has 85 major, 110 moderate, and 113 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Somatuline Depot. Always confirm against the full prescribing information.